Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 100
Summary
- Conditions
- Deep Vein Thrombosis (DVT)
- Surgery
- Thromboembolic Events
- Trauma
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 15 years and 100 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02342444
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Martin A Schreiber, MD Oregon Health and Science University